Identifying a missing lineage driver in a subset of lung neuroendocrine tumors

  1. Jane E. Johnson1,4,5
  1. 1Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA;
  2. 2Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA;
  3. 3Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA;
  4. 4Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA;
  5. 5Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA;
  6. 6Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
  1. Corresponding author: jane.johnson{at}utsouthwestern.edu

Abstract

Tumor heterogeneity of a primary histologic cancer type has major implications for cancer research and therapeutics. An important and understudied aspect of this heterogeneity is the role of transcription factors that serve as “lineage oncogenes” in a tumor type. A demonstration that different subgroups have distinct dependencies on lineage-specific transcription factors is highlighted in a relatively homogenous cancer type: the pulmonary neuroendocrine cancer small cell lung carcinoma (SCLC). Identification of these factors is providing new insights into the origin of the heterogeneity and subtype-specific vulnerabilities in SCLC and provides a template for studying heterogeneity in other cancer types.

Keywords

This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.

Related Article

| Table of Contents

Life Science Alliance